Loading...
OTCM
HBRM
Market cap10kUSD
Jul 09, Last price  
0.00USD
1D
9,900.00%
1Q
9,900.00%
Jan 2017
0.00%
Name

Herborium Group Inc

Chart & Performance

D1W1MN
OTCM:HBRM chart
P/E
P/S
1.39
EPS
Div Yield, %
Shrs. gr., 5y
11.01%
Rev. gr., 5y
-4.52%
Revenues
788k
-25.00%
105,431,200104,938,70088,872,70075,011,70070,328,70074,327,00071,473,500827,755761,884843,200908,600816,300875,000993,5001,051,0001,133,1001,119,4201,051,000788,250
Net income
-155k
L-52.92%
1,775,700827,300121,800-2,850,700-2,835,900-2,128,400-1,892,200-339,757-642,555-54,700-32,200-174,100-76,00047,100-328,770-267,04029,523-328,770-154,770
CFO
370k
P
-2,191,3003,582,8001,161,500-1,634,000-898,000-470,400-1,896,900-24,093-86,0198,80079,600-117,500-71,000-43,40094,100-133,290369,970

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Herborium Group, Inc. operates as a specialized firm in botanical therapeutics, focusing on the creation, licensing, and commercialization of its unique, plant-based medicinal goods for both general consumers and healthcare professionals. Its product range includes dermatological solutions like AcnEase, an herbal treatment designed to alleviate symptoms associated with hormonal acne and various forms of Rosacea. The company also offers the AcnEase Skin Management System, intended to diminish acne marks and scars. Furthermore, Herborium provides non-prescription sexual health and performance products. These serve as alternatives for specific sexual dysfunctions that may arise from cardiovascular conditions, the use of antidepressants, or surgical procedures such as hysterectomies. The company also offers energy-boosting products, notably Lasting Energy. This herbal supplement aims to reduce hangover effects, counteract jet lag, and address general energy depletion caused by intense physical activities, high stress levels, prolonged sexual engagements, or other enduring or temporary physical demands. Additional products in its portfolio include the Liver Activator Series for managing liver damage; ProstAid, a natural remedy specifically formulated for Benign Prostate Hyperplasia (BPH); and CardioVitae, a fermentation-based product utilizing a Lucidium-derived cell line to target cardio-pulmonary insufficiencies. Herborium Group, Inc. distributes its products across the United States, the United Kingdom, and mainland Europe, utilizing a network of distributors, specialty retailers, and its e-commerce platform. The company was founded in 2000 and has its principal office located in Fort Lee, New Jersey.
IPO date
Jul 10, 1998
Employees
2
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑112024‑112023‑112022‑112021‑112020‑112019‑112018‑112017‑112016‑11
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT